GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
PBQQX
Price
$21.50
Change
-$1.35 (-5.91%)
Updated
Apr 3 closing price
Net Assets
991.68M
Ad is loading...

GFACX vs PBQQX

Header iconGFACX vs PBQQX Comparison
Open Charts GFACX vs PBQQXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
PGIM Jennison Blend R6
Price$21.50
Change-$1.35 (-5.91%)
VolumeN/A
Net Assets991.68M
GFACX vs PBQQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. PBQQX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and PBQQX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. PBQQX (992M). PBQQX pays higher dividends than GFACX: PBQQX (0.84) vs GFACX (0.00). GFACX was incepted earlier than PBQQX: GFACX (24 years) vs PBQQX (7 years). PBQQX (2.99) is less costly to investors than GFACX (1.36). PBQQX is a more actively managed with annual turnover of: 47.00 vs. GFACX (25.00). PBQQX has a lower initial minimum investment than GFACX: PBQQX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. PBQQX (-5.91). GFACX (59.73) and PBQQX (57.81) have equivalent 5 years return.
GFACXPBQQXGFACX / PBQQX
Total Expense Ratio1.360.64213%
Annual Report Gross Expense Ratio1.362.9945%
Fund Existence24 years7 years-
Gain YTD-5.003-6.08382%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets280B992M28,226%
Annual Yield % from dividends0.000.84-
Returns for 1 year-1.75-5.9130%
Returns for 3 years0.631.5640%
Returns for 5 years59.7357.81103%
Returns for 10 years44.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences